-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - Title
Appendix D. Evidence Table
Table D-1. Evidence Table
Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report
Author, Year
Country
Number of Centers and Setting Inclusion/Exclusion Criteria Number…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - Title
Appendix D. Evidence Table
Table D-1. Evidence Table
Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report
Author, Year
Country
Number of Centers and Setting Inclusion/Exclusion Criteria Number…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs
Future Research Needs Paper
Number 42
Treatment Strategies for
Women With Coronary
Artery Disease: Future
Research Needs
Future Research Needs Paper
Number 42
Treatment Strategies for Women With Coronary Artery
Disease: Fut…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - CER # 23:
Effectiveness of Recombinant Human Growth Hormone (rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings 1st Assessment:
• All conclusions for KQ…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
January 01, 2022 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
May 29, 2025 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
May 29, 2025 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
March 01, 2013 - to increased weight gain;
the degree to which harms outweigh those benefits likely
depends on the starting
-
digital.ahrq.gov/sites/default/files/docs/page/UMASS%20Final%20Report_0.pdf
April 01, 2007 - The Medicaid Transformation Grants total $150 million over two years
starting in FY 2007.
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - At that stage, EPCs generally give evidence derived from observational studies a low starting
grade
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - chosen patients with an index visit between July 2011 and June 2012 and
abstracted all encounters starting
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Outpatient-Weighted.pdf
September 26, 2023 - 0.01 195,537,366 99.83
69: Discharged/transferred to a designated disaster alternative care site (starting
-
www.ahrq.gov/sites/default/files/wysiwyg/pcor/external-stakeholder-report.pdf
June 23, 2023 - health would
have the greatest impact, or ‘bang for the buck,’ on prevention and health equity by
starting
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - Similarly, because proliferation may occur up to and
after 12 months of age, the effectiveness of starting
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol
for Three Parallel
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - response in total sleep time (e.g.,
zolpidem 10 mg. and eszopiclone 3 mg.) were generally
above the starting
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
October 19, 2016 - Good starting point are
these 2 links:
CDC Infection Prevention Resources for Outpatient
Settings
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
July 01, 2013 - The Effective Health Care Program Selection Criteria provided a
starting point (Appendix A), including
-
hcup-us.ahrq.gov/reports/methods/2008_08.pdf
January 01, 2008 - In an attempt to create uniformly defined
outpatient databases, AHRQ approved, starting with the 2004